

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.40170934 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 5.31530371 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.88370453 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.73368248 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.70390933 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69666442 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.64400527 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.53917601 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49999022 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49999022 |
| 11 | microglial cell activation (GO:0001774) | 4.44400296 |
| 12 | myeloid dendritic cell differentiation (GO:0043011) | 4.32074970 |
| 13 | detection of other organism (GO:0098543) | 4.29588915 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.20500233 |
| 15 | negative T cell selection (GO:0043383) | 4.10109700 |
| 16 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.09814402 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.04613274 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93537297 |
| 19 | myeloid dendritic cell activation (GO:0001773) | 3.92231229 |
| 20 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.84041699 |
| 21 | cellular extravasation (GO:0045123) | 3.82860307 |
| 22 | detection of bacterium (GO:0016045) | 3.80898319 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78678782 |
| 24 | response to host immune response (GO:0052572) | 3.78678782 |
| 25 | macrophage activation (GO:0042116) | 3.77339237 |
| 26 | positive regulation of humoral immune response (GO:0002922) | 3.71479504 |
| 27 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.70411652 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.69922568 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68872203 |
| 30 | positive regulation of interleukin-2 production (GO:0032743) | 3.67660670 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.63634966 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.61493571 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61493571 |
| 34 | regulation of immunoglobulin secretion (GO:0051023) | 3.60905499 |
| 35 | regulation of RIG-I signaling pathway (GO:0039535) | 3.56739041 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.55604409 |
| 37 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.53765087 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.53567584 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.52642895 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.52293321 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47945407 |
| 42 | positive regulation of interleukin-12 production (GO:0032735) | 3.47774464 |
| 43 | response to host (GO:0075136) | 3.43457893 |
| 44 | response to host defenses (GO:0052200) | 3.43457893 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.43457893 |
| 46 | response to type I interferon (GO:0034340) | 3.42413824 |
| 47 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.42093516 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.41929787 |
| 49 | T cell migration (GO:0072678) | 3.41575979 |
| 50 | regulation of chronic inflammatory response (GO:0002676) | 3.40996115 |
| 51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40330743 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.40223231 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.40223231 |
| 54 | positive regulation of T cell cytokine production (GO:0002726) | 3.35520048 |
| 55 | regulation of interferon-alpha production (GO:0032647) | 3.35404477 |
| 56 | positive regulation of isotype switching (GO:0045830) | 3.34255598 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34251943 |
| 58 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.34216176 |
| 59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33101471 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 3.31443516 |
| 61 | neutrophil mediated immunity (GO:0002446) | 3.30868766 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 3.26588841 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.26010943 |
| 64 | regulation of interleukin-12 production (GO:0032655) | 3.24908583 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.24751784 |
| 66 | dendritic cell differentiation (GO:0097028) | 3.24454025 |
| 67 | response to interleukin-15 (GO:0070672) | 3.23083569 |
| 68 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.22848626 |
| 69 | natural killer cell mediated immunity (GO:0002228) | 3.22848626 |
| 70 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.21397168 |
| 71 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.21377445 |
| 72 | T-helper cell differentiation (GO:0042093) | 3.21377445 |
| 73 | positive regulation of mast cell activation (GO:0033005) | 3.21159866 |
| 74 | germinal center formation (GO:0002467) | 3.20182145 |
| 75 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20067829 |
| 76 | modulation by symbiont of host immune response (GO:0052553) | 3.20067829 |
| 77 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20067829 |
| 78 | modulation by symbiont of host defense response (GO:0052031) | 3.20067829 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20067829 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20067829 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19750987 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19118280 |
| 83 | regulation of T-helper cell differentiation (GO:0045622) | 3.15406673 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15364373 |
| 85 | granulocyte activation (GO:0036230) | 3.12784586 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 3.12552764 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11720983 |
| 88 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10982681 |
| 89 | negative regulation of interleukin-12 production (GO:0032695) | 3.10542778 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09892759 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 3.08761000 |
| 92 | defense response to protozoan (GO:0042832) | 3.08491483 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07977776 |
| 94 | positive regulation of B cell mediated immunity (GO:0002714) | 3.06778569 |
| 95 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.06778569 |
| 96 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.06765183 |
| 97 | neutrophil activation (GO:0042119) | 3.06758182 |
| 98 | response to peptidoglycan (GO:0032494) | 3.05770782 |
| 99 | thymic T cell selection (GO:0045061) | 3.04675186 |
| 100 | tolerance induction (GO:0002507) | 3.04352530 |
| 101 | regulation of hypersensitivity (GO:0002883) | 3.03631302 |
| 102 | positive thymic T cell selection (GO:0045059) | 3.02426041 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 3.01924269 |
| 104 | myeloid leukocyte mediated immunity (GO:0002444) | 3.00916617 |
| 105 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00328713 |
| 106 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.98825356 |
| 107 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.98588418 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.98335885 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97940740 |
| 110 | B cell mediated immunity (GO:0019724) | 2.96466325 |
| 111 | leukocyte aggregation (GO:0070486) | 2.96341058 |
| 112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96094200 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 2.95709311 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.95670585 |
| 115 | T cell selection (GO:0045058) | 2.95594655 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95348052 |
| 117 | response to protozoan (GO:0001562) | 2.94297077 |
| 118 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94110942 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93411844 |
| 120 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91325913 |
| 121 | positive regulation of type 2 immune response (GO:0002830) | 2.90454512 |
| 122 | T-helper 1 type immune response (GO:0042088) | 2.89231940 |
| 123 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.85431305 |
| 124 | T cell costimulation (GO:0031295) | 2.85270893 |
| 125 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.84405367 |
| 126 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.83820576 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83301470 |
| 128 | cellular response to interleukin-15 (GO:0071350) | 2.82876785 |
| 129 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82682862 |
| 130 | lymphocyte costimulation (GO:0031294) | 2.82656285 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.82100820 |
| 132 | T cell differentiation involved in immune response (GO:0002292) | 2.81643064 |
| 133 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.81643064 |
| 134 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.81643064 |
| 135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80883680 |
| 136 | hepatocyte apoptotic process (GO:0097284) | 2.80868298 |
| 137 | positive regulation of activated T cell proliferation (GO:0042104) | 2.80134462 |
| 138 | positive regulation of DNA recombination (GO:0045911) | 2.79096776 |
| 139 | cellular response to ethanol (GO:0071361) | 2.78886670 |
| 140 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.78488973 |
| 141 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.77893701 |
| 142 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76920962 |
| 143 | positive regulation of mast cell degranulation (GO:0043306) | 2.76920962 |
| 144 | positive regulation of interferon-beta production (GO:0032728) | 2.76911230 |
| 145 | leukocyte degranulation (GO:0043299) | 2.76770457 |
| 146 | respiratory burst (GO:0045730) | 2.76758525 |
| 147 | negative regulation of B cell proliferation (GO:0030889) | 2.76291849 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.74552502 |
| 149 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73958056 |
| 150 | natural killer cell activation (GO:0030101) | 2.73741687 |
| 151 | regulation of type 2 immune response (GO:0002828) | 2.72949220 |
| 152 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.72426425 |
| 153 | regulation of necroptotic process (GO:0060544) | 2.71133028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.27766020 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.48368085 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.80785964 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.60787142 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31467469 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.21117692 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.88784270 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.62227081 |
| 9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.55689070 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34205276 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.32089267 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11224285 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.08809042 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96783000 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.90090813 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87834556 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87178271 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.82160641 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60895911 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60812347 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44769272 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35766578 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.35073976 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18101192 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.15327877 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 1.97687530 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74202770 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.68424485 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67876867 |
| 30 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65066978 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64498705 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62086597 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61848602 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61718907 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59321938 |
| 36 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58474437 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.58248020 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55151969 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55130314 |
| 40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.54048566 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52230820 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51471783 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47766960 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42483188 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41053997 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36190664 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35833249 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34995994 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33554287 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29413897 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28885903 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26795480 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26078829 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22314900 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19855205 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15467421 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15145483 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14192230 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.13799659 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13594077 |
| 61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13364772 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12994100 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11856193 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09375565 |
| 65 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03507895 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02383010 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02358061 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02358061 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01470759 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01324743 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01006685 |
| 72 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00056452 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98475527 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97382974 |
| 75 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95723434 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95514354 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94972330 |
| 78 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.94563756 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93253958 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92109303 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91669735 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91380595 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91060356 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91001526 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90745854 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89514810 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85027921 |
| 88 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84700961 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83942635 |
| 90 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83887542 |
| 91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83492847 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82999634 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82597687 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82385995 |
| 95 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80650698 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80161841 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79773368 |
| 98 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78778926 |
| 99 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77067810 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.76535178 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76133230 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75316966 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73447530 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.72285708 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71076364 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70804125 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70542327 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70118194 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.69177648 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68735459 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68197948 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68163510 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67914794 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67414853 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67304629 |
| 116 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.66295482 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66102279 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66048113 |
| 119 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.65835521 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64349305 |
| 121 | GATA3_26560356_Chip-Seq_TH1_Human | 0.64296979 |
| 122 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62973410 |
| 123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.61793808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.30288403 |
| 2 | MP0003303_peritoneal_inflammation | 3.71282886 |
| 3 | MP0000685_abnormal_immune_system | 3.54041662 |
| 4 | MP0003436_decreased_susceptibility_to | 3.35261918 |
| 5 | MP0005671_abnormal_response_to | 3.33548003 |
| 6 | MP0009785_altered_susceptibility_to | 3.21951080 |
| 7 | MP0005387_immune_system_phenotype | 3.20897828 |
| 8 | MP0001790_abnormal_immune_system | 3.20897828 |
| 9 | MP0004510_myositis | 3.05308020 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.96983524 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.90862685 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.79718270 |
| 13 | MP0001800_abnormal_humoral_immune | 2.79045426 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.61267397 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.56929040 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.56305186 |
| 17 | MP0005025_abnormal_response_to | 2.52473350 |
| 18 | MP0002723_abnormal_immune_serum | 2.51172620 |
| 19 | MP0002006_tumorigenesis | 2.50927300 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.47898979 |
| 21 | MP0002419_abnormal_innate_immunity | 2.37085352 |
| 22 | MP0001819_abnormal_immune_cell | 2.30544224 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.28348965 |
| 24 | MP0006082_CNS_inflammation | 2.24640133 |
| 25 | MP0002405_respiratory_system_inflammati | 2.15970178 |
| 26 | MP0001853_heart_inflammation | 2.13922054 |
| 27 | MP0003724_increased_susceptibility_to | 2.13754609 |
| 28 | MP0005310_abnormal_salivary_gland | 2.11273598 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 2.04901776 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.02390845 |
| 31 | MP0004947_skin_inflammation | 1.99822991 |
| 32 | MP0008260_abnormal_autophagy | 1.96220773 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.94938033 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.94081631 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.88702347 |
| 36 | * MP0000716_abnormal_immune_system | 1.83122641 |
| 37 | MP0002254_reproductive_system_inflammat | 1.80082952 |
| 38 | MP0001873_stomach_inflammation | 1.76775572 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.70426387 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.68892902 |
| 41 | MP0003448_altered_tumor_morphology | 1.68032148 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.66419640 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.65971571 |
| 44 | MP0004883_abnormal_blood_vessel | 1.60540585 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.55523151 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.52769160 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.49346232 |
| 48 | MP0009764_decreased_sensitivity_to | 1.46953179 |
| 49 | * MP0002429_abnormal_blood_cell | 1.44610869 |
| 50 | * MP0000689_abnormal_spleen_morphology | 1.41503099 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.40988221 |
| 52 | * MP0002722_abnormal_immune_system | 1.40947397 |
| 53 | MP0002009_preneoplasia | 1.40360868 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.37688824 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.36236512 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.35751174 |
| 57 | MP0003866_abnormal_defecation | 1.35279266 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.34814885 |
| 59 | MP0008004_abnormal_stomach_pH | 1.32975736 |
| 60 | MP0005164_abnormal_response_to | 1.25583200 |
| 61 | MP0003091_abnormal_cell_migration | 1.25544414 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.25387646 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.24955335 |
| 64 | MP0009278_abnormal_bone_marrow | 1.22921276 |
| 65 | MP0002933_joint_inflammation | 1.20990598 |
| 66 | MP0003690_abnormal_glial_cell | 1.20980453 |
| 67 | MP0008469_abnormal_protein_level | 1.20280120 |
| 68 | MP0010307_abnormal_tumor_latency | 1.17597314 |
| 69 | MP0002132_abnormal_respiratory_system | 1.17490593 |
| 70 | MP0003646_muscle_fatigue | 1.17187038 |
| 71 | MP0004130_abnormal_muscle_cell | 1.14405277 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12953939 |
| 73 | MP0000858_altered_metastatic_potential | 1.12893912 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.11456509 |
| 75 | * MP0004808_abnormal_hematopoietic_stem | 1.08660619 |
| 76 | * MP0001545_abnormal_hematopoietic_system | 1.06467695 |
| 77 | * MP0005397_hematopoietic_system_phenotyp | 1.06467695 |
| 78 | MP0000604_amyloidosis | 1.04913208 |
| 79 | MP0004484_altered_response_of | 1.04115640 |
| 80 | MP0008057_abnormal_DNA_replication | 1.02122961 |
| 81 | MP0006054_spinal_hemorrhage | 1.02052041 |
| 82 | MP0000490_abnormal_crypts_of | 1.01523283 |
| 83 | MP0002163_abnormal_gland_morphology | 1.00098615 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.98127347 |
| 85 | MP0004381_abnormal_hair_follicle | 0.92617222 |
| 86 | MP0001851_eye_inflammation | 0.92605166 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.89862245 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.89461846 |
| 89 | MP0003075_altered_response_to | 0.84949389 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.82971336 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.81453101 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.80036899 |
| 93 | MP0005390_skeleton_phenotype | 0.79628413 |
| 94 | MP0003045_fibrosis | 0.78543214 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.77684794 |
| 96 | MP0000343_altered_response_to | 0.77278256 |
| 97 | * MP0001881_abnormal_mammary_gland | 0.77251358 |
| 98 | * MP0000627_abnormal_mammary_gland | 0.77112258 |
| 99 | MP0009763_increased_sensitivity_to | 0.71880544 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.71798947 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.70469587 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.69836957 |
| 103 | MP0005166_decreased_susceptibility_to | 0.69510986 |
| 104 | MP0003828_pulmonary_edema | 0.69237954 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.69064786 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.68740465 |
| 107 | MP0008874_decreased_physiological_sensi | 0.68015846 |
| 108 | MP0000249_abnormal_blood_vessel | 0.67898112 |
| 109 | MP0000733_abnormal_muscle_development | 0.67069267 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.66638961 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.65692614 |
| 112 | MP0005023_abnormal_wound_healing | 0.64511523 |
| 113 | MP0001663_abnormal_digestive_system | 0.63680457 |
| 114 | * MP0002019_abnormal_tumor_incidence | 0.62437424 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.61524332 |
| 116 | * MP0003795_abnormal_bone_structure | 0.60975602 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.60761927 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.60507627 |
| 119 | MP0005451_abnormal_body_composition | 0.58866953 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.57443801 |
| 121 | MP0001915_intracranial_hemorrhage | 0.57240520 |
| 122 | MP0009115_abnormal_fat_cell | 0.56122394 |
| 123 | MP0005409_darkened_coat_color | 0.52844614 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.52023635 |
| 125 | MP0005621_abnormal_cell_physiology | 0.51673681 |
| 126 | MP0001191_abnormal_skin_condition | 0.51193080 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.51126066 |
| 128 | MP0000371_diluted_coat_color | 0.50038583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.68859378 |
| 2 | Optic neuritis (HP:0100653) | 4.80594790 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.80594790 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.67456259 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.57900637 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.55962281 |
| 7 | Stomatitis (HP:0010280) | 4.49834796 |
| 8 | Orchitis (HP:0100796) | 4.43121227 |
| 9 | Myositis (HP:0100614) | 4.41393247 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37055479 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.34774011 |
| 12 | Recurrent viral infections (HP:0004429) | 4.32477656 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.24204272 |
| 14 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.13220306 |
| 15 | Vasculitis (HP:0002633) | 4.01298755 |
| 16 | Pulmonary infiltrates (HP:0002113) | 3.76333996 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.57406677 |
| 18 | Prolonged bleeding time (HP:0003010) | 3.47827819 |
| 19 | Increased IgM level (HP:0003496) | 3.45690916 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34773939 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34773939 |
| 22 | T lymphocytopenia (HP:0005403) | 3.33344573 |
| 23 | Chronic otitis media (HP:0000389) | 3.31766893 |
| 24 | Recurrent skin infections (HP:0001581) | 3.29913863 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29879199 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.27701114 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23178372 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.06210600 |
| 29 | Prostate neoplasm (HP:0100787) | 3.03401557 |
| 30 | * Gingival bleeding (HP:0000225) | 2.98937829 |
| 31 | Hemoptysis (HP:0002105) | 2.98247452 |
| 32 | Abnormality of T cells (HP:0002843) | 2.97084792 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.93098045 |
| 34 | Obstructive lung disease (HP:0006536) | 2.93098045 |
| 35 | * Epistaxis (HP:0000421) | 2.92337842 |
| 36 | Gingivitis (HP:0000230) | 2.88183240 |
| 37 | * Arterial thrombosis (HP:0004420) | 2.87963018 |
| 38 | Hematochezia (HP:0002573) | 2.86630320 |
| 39 | Pustule (HP:0200039) | 2.86152897 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.84044788 |
| 41 | Chronic diarrhea (HP:0002028) | 2.79869900 |
| 42 | Urticaria (HP:0001025) | 2.76813339 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.76561732 |
| 44 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72290643 |
| 45 | Osteolytic defects of the hand bones (HP:0009699) | 2.72290643 |
| 46 | Meningitis (HP:0001287) | 2.71867695 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.69279037 |
| 48 | Periodontitis (HP:0000704) | 2.68305387 |
| 49 | Hypergammaglobulinemia (HP:0010702) | 2.66824747 |
| 50 | IgA deficiency (HP:0002720) | 2.65748108 |
| 51 | Increased IgE level (HP:0003212) | 2.64883448 |
| 52 | Keratoconjunctivitis (HP:0001096) | 2.61509609 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.61351208 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.60618063 |
| 55 | Persistence of primary teeth (HP:0006335) | 2.60067776 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.59883043 |
| 57 | Nasal polyposis (HP:0100582) | 2.57233999 |
| 58 | Amyloidosis (HP:0011034) | 2.55073220 |
| 59 | Basal ganglia calcification (HP:0002135) | 2.51569370 |
| 60 | Eosinophilia (HP:0001880) | 2.50824082 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.48550965 |
| 62 | Porencephaly (HP:0002132) | 2.46521075 |
| 63 | Cellulitis (HP:0100658) | 2.40993014 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.34322106 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.34071068 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.32955323 |
| 67 | Absent frontal sinuses (HP:0002688) | 2.32016729 |
| 68 | Joint swelling (HP:0001386) | 2.30964784 |
| 69 | Episodic fever (HP:0001954) | 2.30962703 |
| 70 | * Leukocytosis (HP:0001974) | 2.30166379 |
| 71 | Increased density of long bones (HP:0006392) | 2.27298092 |
| 72 | Encephalitis (HP:0002383) | 2.26705427 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.26327073 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25762938 |
| 75 | Colitis (HP:0002583) | 2.25166459 |
| 76 | Lymphopenia (HP:0001888) | 2.24197876 |
| 77 | * Gastrointestinal infarctions (HP:0005244) | 2.23242760 |
| 78 | Gangrene (HP:0100758) | 2.22486186 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.20724700 |
| 80 | IgG deficiency (HP:0004315) | 2.19941565 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.18379779 |
| 82 | Pulmonary embolism (HP:0002204) | 2.17734715 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15953412 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.15821335 |
| 85 | Combined immunodeficiency (HP:0005387) | 2.15421468 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.15080188 |
| 87 | Emphysema (HP:0002097) | 2.13962408 |
| 88 | Abnormality of the pericardium (HP:0001697) | 2.13946513 |
| 89 | * Chest pain (HP:0100749) | 2.10446829 |
| 90 | * Vertigo (HP:0002321) | 2.10039151 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09748186 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09748186 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09748186 |
| 94 | Polyneuropathy (HP:0001271) | 2.08517768 |
| 95 | Thyroiditis (HP:0100646) | 2.07184318 |
| 96 | Thick nail (HP:0001805) | 2.07003577 |
| 97 | Glomerulopathy (HP:0100820) | 2.06877807 |
| 98 | Tetraparesis (HP:0002273) | 2.04862047 |
| 99 | Agammaglobulinemia (HP:0004432) | 2.03078878 |
| 100 | Granulocytopenia (HP:0001913) | 1.99847370 |
| 101 | Osteomyelitis (HP:0002754) | 1.98525077 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 1.97823120 |
| 103 | Abnormality of the pleura (HP:0002103) | 1.97560673 |
| 104 | Anorexia (HP:0002039) | 1.97385079 |
| 105 | * Arthralgia (HP:0002829) | 1.97257036 |
| 106 | Viral hepatitis (HP:0006562) | 1.95970181 |
| 107 | Spinal cord lesions (HP:0100561) | 1.95464371 |
| 108 | Syringomyelia (HP:0003396) | 1.95464371 |
| 109 | Conjunctival telangiectasia (HP:0000524) | 1.93403994 |
| 110 | Postural instability (HP:0002172) | 1.92812008 |
| 111 | Disinhibition (HP:0000734) | 1.91803513 |
| 112 | Purpura (HP:0000979) | 1.91745046 |
| 113 | Increased serum ferritin (HP:0003281) | 1.88332607 |
| 114 | Poikilocytosis (HP:0004447) | 1.87879871 |
| 115 | Petechiae (HP:0000967) | 1.87757905 |
| 116 | Microcytic anemia (HP:0001935) | 1.87431808 |
| 117 | * Acute myeloid leukemia (HP:0004808) | 1.87087354 |
| 118 | Abnormality of the endocardium (HP:0004306) | 1.86618201 |
| 119 | B lymphocytopenia (HP:0010976) | 1.86426904 |
| 120 | Abnormality of B cell number (HP:0010975) | 1.86426904 |
| 121 | Restrictive lung disease (HP:0002091) | 1.86223477 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.85725473 |
| 123 | Subacute progressive viral hepatitis (HP:0006572) | 1.83410504 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.81452459 |
| 125 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81059124 |
| 126 | Skin ulcer (HP:0200042) | 1.80935782 |
| 127 | Sepsis (HP:0100806) | 1.79833845 |
| 128 | Hypochromic microcytic anemia (HP:0004840) | 1.78303291 |
| 129 | * Thrombophlebitis (HP:0004418) | 1.77032696 |
| 130 | Recurrent pneumonia (HP:0006532) | 1.75377653 |
| 131 | Papillary thyroid carcinoma (HP:0002895) | 1.74338717 |
| 132 | Keratitis (HP:0000491) | 1.73415799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.96648452 |
| 2 | TXK | 3.97683121 |
| 3 | MAP4K1 | 3.37618507 |
| 4 | TYK2 | 3.33048236 |
| 5 | IKBKB | 2.89792598 |
| 6 | TBK1 | 2.83284770 |
| 7 | MAP3K13 | 2.73352661 |
| 8 | * JAK3 | 2.69185289 |
| 9 | JAK1 | 2.54796573 |
| 10 | IKBKE | 2.53353295 |
| 11 | RIPK4 | 2.52842264 |
| 12 | CHUK | 2.43882575 |
| 13 | PRPF4B | 2.23853288 |
| 14 | LATS1 | 1.97126261 |
| 15 | ZAP70 | 1.86224562 |
| 16 | PIK3CG | 1.85084877 |
| 17 | EPHB1 | 1.82306787 |
| 18 | FGFR3 | 1.76019051 |
| 19 | EPHA3 | 1.73649005 |
| 20 | IRAK4 | 1.73608077 |
| 21 | IRAK3 | 1.64632638 |
| 22 | FGFR4 | 1.57753933 |
| 23 | NEK9 | 1.51025936 |
| 24 | MATK | 1.50720593 |
| 25 | STK10 | 1.42468228 |
| 26 | TAOK3 | 1.40518014 |
| 27 | TRIB3 | 1.36486552 |
| 28 | BLK | 1.34095039 |
| 29 | TEC | 1.31938341 |
| 30 | CSK | 1.31848329 |
| 31 | TAOK1 | 1.30615732 |
| 32 | STK3 | 1.30237768 |
| 33 | KIT | 1.29548293 |
| 34 | CDK12 | 1.28172970 |
| 35 | ITK | 1.26417487 |
| 36 | HCK | 1.26349872 |
| 37 | RPS6KA4 | 1.23176706 |
| 38 | LCK | 1.21358493 |
| 39 | MST4 | 1.19064805 |
| 40 | PIM1 | 1.18753452 |
| 41 | GRK7 | 1.18279754 |
| 42 | * JAK2 | 1.11225012 |
| 43 | PIM2 | 1.09425751 |
| 44 | MAP3K6 | 1.09039356 |
| 45 | NLK | 1.08072583 |
| 46 | BTK | 1.06684107 |
| 47 | MAP3K2 | 1.05580566 |
| 48 | SYK | 1.05176275 |
| 49 | CAMKK2 | 1.04658288 |
| 50 | PDGFRB | 0.95175886 |
| 51 | IRAK2 | 0.92550764 |
| 52 | YES1 | 0.92058577 |
| 53 | TNK2 | 0.88653231 |
| 54 | PRKCQ | 0.87217526 |
| 55 | OBSCN | 0.86832165 |
| 56 | PBK | 0.85527096 |
| 57 | MARK3 | 0.85274051 |
| 58 | MAP3K5 | 0.84744535 |
| 59 | TTN | 0.81929563 |
| 60 | SGK2 | 0.81753627 |
| 61 | CSF1R | 0.81671901 |
| 62 | DMPK | 0.79560499 |
| 63 | EEF2K | 0.79289647 |
| 64 | BMPR2 | 0.78823072 |
| 65 | PTK2B | 0.78105971 |
| 66 | SGK3 | 0.78016666 |
| 67 | PTK6 | 0.77452320 |
| 68 | WNK1 | 0.77185497 |
| 69 | BMX | 0.76866292 |
| 70 | RAF1 | 0.76809377 |
| 71 | LRRK2 | 0.76638012 |
| 72 | ERN1 | 0.71729651 |
| 73 | STK4 | 0.71115315 |
| 74 | TRPM7 | 0.71043269 |
| 75 | RIPK1 | 0.69163873 |
| 76 | KSR2 | 0.67119493 |
| 77 | MAP2K3 | 0.66721953 |
| 78 | PDPK1 | 0.66068643 |
| 79 | MAPK12 | 0.65768438 |
| 80 | CDK9 | 0.65475988 |
| 81 | MARK2 | 0.64686178 |
| 82 | CDC42BPA | 0.63465016 |
| 83 | LYN | 0.62816774 |
| 84 | BRD4 | 0.62816228 |
| 85 | FRK | 0.62545941 |
| 86 | * ABL1 | 0.62224574 |
| 87 | KSR1 | 0.60796264 |
| 88 | RET | 0.60399846 |
| 89 | MELK | 0.59600905 |
| 90 | FGR | 0.57325246 |
| 91 | ALK | 0.56691964 |
| 92 | MAPK7 | 0.54656327 |
| 93 | IRAK1 | 0.53566670 |
| 94 | CDK6 | 0.52710264 |
| 95 | ABL2 | 0.52509489 |
| 96 | MAP3K10 | 0.51633699 |
| 97 | SIK2 | 0.50825389 |
| 98 | MAP3K8 | 0.50643963 |
| 99 | MAPKAPK2 | 0.50005048 |
| 100 | MAP2K4 | 0.49100186 |
| 101 | PRKAA2 | 0.48937612 |
| 102 | EGFR | 0.48689901 |
| 103 | MOS | 0.47659335 |
| 104 | MAP3K1 | 0.47654368 |
| 105 | NUAK1 | 0.47648727 |
| 106 | MAP3K7 | 0.47125239 |
| 107 | DYRK1B | 0.45860969 |
| 108 | MAP3K3 | 0.44873350 |
| 109 | STK24 | 0.44598532 |
| 110 | FYN | 0.43605367 |
| 111 | PKN2 | 0.42110469 |
| 112 | ERBB4 | 0.41473648 |
| 113 | HIPK2 | 0.41330249 |
| 114 | GRK6 | 0.41126563 |
| 115 | MAP3K11 | 0.40995426 |
| 116 | PDK1 | 0.39212817 |
| 117 | MAPK11 | 0.37120445 |
| 118 | TAOK2 | 0.36590658 |
| 119 | CLK1 | 0.35590495 |
| 120 | TYRO3 | 0.34325546 |
| 121 | FES | 0.33956126 |
| 122 | STK11 | 0.33744422 |
| 123 | PRKCH | 0.33454516 |
| 124 | RPS6KA1 | 0.33355333 |
| 125 | LATS2 | 0.31834792 |
| 126 | PKN1 | 0.31288852 |
| 127 | ACVR1B | 0.30474572 |
| 128 | SGK1 | 0.30043457 |
| 129 | SIK3 | 0.29941940 |
| 130 | CDK4 | 0.29409400 |
| 131 | TGFBR2 | 0.28720579 |
| 132 | PDGFRA | 0.28544043 |
| 133 | CAMK1D | 0.28138585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.34230546 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.91934322 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80016812 |
| 4 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.63865048 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57790891 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50461554 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.28331682 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25039888 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22318753 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19771002 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.19063086 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19016274 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.15490362 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00240918 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95566521 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.91908714 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89804486 |
| 18 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.86252118 |
| 19 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.76842321 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.73737672 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72867382 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66140647 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.62920225 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.62044694 |
| 25 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.60793961 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56079008 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.53866163 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52125241 |
| 29 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50329504 |
| 30 | * Tuberculosis_Homo sapiens_hsa05152 | 1.47114490 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45844908 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43774418 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.41788922 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41639828 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.37659640 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.36729939 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34358244 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33713717 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31836263 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28798730 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.26111057 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24227865 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24205616 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23407818 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22206817 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20897026 |
| 47 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20851897 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.16264411 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13575687 |
| 50 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11618727 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.02101201 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96855443 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94215323 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83431461 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81316103 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80342136 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.80171239 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79832778 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79761173 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.79475620 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77413320 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76542849 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73690094 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72842228 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70462683 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68255954 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68061318 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66409340 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64765086 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64424780 |
| 71 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63008436 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60926579 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.60424652 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59555342 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.58608748 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56275846 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55456170 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55042788 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53468334 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51546009 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51468888 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50775698 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50339808 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49834541 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49704680 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49276653 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49153502 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47210147 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44630849 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.43476263 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43113914 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.42896334 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42818504 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42612926 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41031641 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40862604 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40050548 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.38586384 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37483999 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36615972 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36571653 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36164312 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35723783 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35505533 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34463101 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.33302088 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.33244800 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30691047 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30141918 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29204454 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27720861 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26938625 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.26438936 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26320130 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23625036 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22341791 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21391905 |

